EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Disrupted endocannabinoid signaling contributes to systemic inflammation in acute pancreatitis

Paula Goncalves-Romeu iD, Karina Cárdenas-Jaen, Enrique de-Madaria iD, José María Hernández, Lourdes Fluvià, Laura Torres-Ribas iD, Daniel Closa iD, Raquel Guillamat-Prats iD

The Journal of Pathology · 2026

DOI: 10.1002/path.70076 ↗

At a glance

Journal article in The Journal of Pathology, 2026. Written by Paula Goncalves-Romeu and 7 co-authors. Institution: Respiratory and Immune Repair Group (REPAIR), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. Major MEDLINE topics: Endocannabinoids, Pancreatitis, Arachidonic Acids, Receptor, Cannabinoid, CB2. Cited 1 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Instituto de Salud Carlos III, MCIN/AEI, Asociacion Española de Gastroenterología.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Acute pancreatitis (AP) is an inflammatory disease that can lead to systemic complications in severe cases. The endocannabinoid system has emerged as a potential modulator of inflammation in AP. We investigated the role of the endocannabinoid 2‐arachidonoylglycerol (2‐AG) and the cannabinoid receptors CB1 and CB2 during AP. A severity‐dependent decrease in circulating 2‐AG was found both in patients and a murine AP model. Restoring 2‐AG – by avoiding its degradation via monoacylglycerol lipase inhibitor or direct 2‐AG administration – reduced local and systemic inflammation, modulated peritoneal macrophage polarization, and mitigated lung injury. Notably, endocannabinoid system effects were consistent across sexes. Both cannabinoid receptors were involved in disease pathophysiology. Genetic Cnr1 knockout and pharmacological CB2 blockade showed distinct and complementary roles of both receptors in regulating inflammation, immune infiltration, and pulmonary damage. These findings highlight a protective role for 2‐AG and highlight the endocannabinoid system – and cannabinoid receptors in particular – as a promising therapeutic target to modulate inflammation and reduce systemic complications in acute pancreatitis. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

EndocannabinoidsPancreatitisArachidonic AcidsReceptor, Cannabinoid, CB2Receptor, Cannabinoid, CB1GlyceridesInflammationAnimalsHumansFemaleSignal TransductionMaleMiceDisease Models, AnimalMice, KnockoutAcute Disease

Author keywords

2‐AGacute lung injurycannabinoid receptorsendocannabinoidsinflammationmacrophagespancreatitis

Substances

EndocannabinoidsArachidonic AcidsReceptor, Cannabinoid, CB2glyceryl 2-arachidonateReceptor, Cannabinoid, CB1GlyceridesCNR1 protein, mouseCnr2 protein, mouse

Authors and institutions

  • Respiratory and Immune Repair Group (REPAIR), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
  • Faculty of Biosciences, Universitat Autonoma de Barcelona (UAB), Bellaterra, Spain.
  • Department of Clinical Medicine, Miguel Hernandez University, Elche, Spain.
  • Department of Gastroenterology, Dr. Balmis General University Hospital, ISABIAL, Alicante, Spain.
  • Centre for Biomedical Research, Network on Liver and Digestive Diseases (CIBEREHD), Madrid, Spain.
  • Proteomics and Metabolomics Core Facility, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.

ORCID profiles: Paula Goncalves-Romeu, Enrique de-Madaria, Laura Torres-Ribas, Daniel Closa, Raquel Guillamat-Prats

Funding

  • Instituto de Salud Carlos III
  • MCIN/AEI
  • Asociacion Española de Gastroenterología
  • FI-STEP Department of Research and Universities of the Generalitat de Catalunya

Cite

APA

Goncalves-Romeu, P., Cárdenas-Jaen, K., de-Madaria, E., Hernández, J. M., Fluvià, L., Torres-Ribas, L., Closa, D., & Guillamat-Prats, R. (2026). Disrupted endocannabinoid signaling contributes to systemic inflammation in acute pancreatitis. The Journal of Pathology. https://doi.org/10.1002/path.70076

Vancouver

Goncalves-Romeu P, Cárdenas-Jaen K, de-Madaria E, Hernández JM, Fluvià L, Torres-Ribas L, et al. Disrupted endocannabinoid signaling contributes to systemic inflammation in acute pancreatitis. The Journal of Pathology. 2026. doi:10.1002/path.70076

BibTeX
@article{GoncalvesRomeu2026,
  author = {Goncalves-Romeu, Paula and Cárdenas-Jaen, Karina and de-Madaria, Enrique and Hernández, José María and Fluvià, Lourdes and Torres-Ribas, Laura and Closa, Daniel and Guillamat-Prats, Raquel},
  title = {Disrupted endocannabinoid signaling contributes to systemic inflammation in acute pancreatitis},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.70076}
}
Start for free →